Biotechnology
The Biotechnology industry has a total of 601 stocks, with a combined market cap of $1.14 trillion and total revenue of $107.24 billion.
Market Cap
1.14T
Revenue
107.24B
Profits
-42.49B
PE Ratio
n/a
Profit Margin
-39.63%
Dividend Yield
0.04%
601 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 121.15B | 1.63% | 1,006,566 | 12.00B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 80.01B | -0.23% | 615,161 | 14.34B |
| 3 | ARGX | argenx SE | 52.09B | -0.34% | 245,319 | 3.68B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 44.59B | -0.94% | 1,375,225 | 3.71B |
| 5 | ONC | BeOne Medicines AG | 40.07B | 2.16% | 195,587 | 4.97B |
| 6 | INSM | Insmed Incorporated | 35.55B | 2.43% | 4,138,170 | 606.42M |
| 7 | BNTX | BioNTech SE | 27.64B | -0.25% | 946,226 | 3.70B |
| 8 | RPRX | Royalty Pharma plc | 26.03B | 0.55% | 3,465,196 | 2.38B |
| 9 | INCY | Incyte Corporation | 20.16B | -0.40% | 1,508,726 | 5.14B |
| 10 | RVMD | Revolution Medicines, Inc. | 19.69B | -0.89% | 1,694,596 | - |
| 11 | MRNA | Moderna, Inc. | 19.49B | 0.34% | 9,024,764 | 1.94B |
| 12 | ROIV | Roivant Sciences Ltd. | 19.43B | -1.34% | 4,679,802 | 13.31M |
| 13 | GMAB | Genmab A/S | 18.01B | 1.35% | 2,094,680 | 3.72B |
| 14 | ASND | Ascendis Pharma A/S | 13.81B | -2.26% | 950,452 | 845.52M |
| 15 | IONS | Ionis Pharmaceuticals, Inc. | 13.47B | - | 2,880,678 | 966.96M |
| 16 | BBIO | BridgeBio Pharma, Inc. | 13.13B | -3.65% | 5,075,611 | 353.78M |
| 17 | BMRN | BioMarin Pharmaceutical Inc. | 12.31B | 1.04% | 3,634,209 | 3.09B |
| 18 | SMMT | Summit Therapeutics Inc. | 12.29B | 0.44% | 2,446,726 | - |
| 19 | EXEL | Exelixis, Inc. | 11.33B | -1.20% | 1,959,186 | 2.32B |
| 20 | RNA | Avidity Biosciences, Inc. | 10.98B | - | 8,082,825 | 20.87M |
| 21 | JAZZ | Jazz Pharmaceuticals plc | 10.46B | 1.53% | 1,366,072 | 4.16B |
| 22 | ABVX | ABIVAX Société Anonyme | 10.31B | 0.08% | 739,726 | 6.23M |
| 23 | MDGL | Madrigal Pharmaceuticals, Inc. | 9.98B | -0.43% | 468,942 | 958.40M |
| 24 | PRAX | Praxis Precision Medicines, Inc. | 9.30B | 1.11% | 648,730 | 7.46M |
| 25 | AXSM | Axsome Therapeutics, Inc. | 9.26B | -1.32% | 573,864 | 561.26M |
| 26 | TECH | Bio-Techne Corporation | 9.00B | -1.25% | 2,643,651 | 1.22B |
| 27 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.90B | -0.42% | 2,749,802 | 1.09B |
| 28 | IBRX | ImmunityBio, Inc. | 8.57B | 1.05% | 45,429,760 | 82.56M |
| 29 | PCVX | Vaxcyte, Inc. | 8.40B | 2.08% | 1,093,727 | - |
| 30 | HALO | Halozyme Therapeutics, Inc. | 8.38B | -1.47% | 2,234,861 | 1.40B |
| 31 | CYTK | Cytokinetics, Incorporated | 8.31B | 0.16% | 2,024,673 | 87.21M |
| 32 | NUVL | Nuvalent, Inc. | 7.80B | -3.42% | 556,790 | - |
| 33 | KRYS | Krystal Biotech, Inc. | 7.65B | -0.33% | 337,445 | 389.13M |
| 34 | KYMR | Kymera Therapeutics, Inc. | 6.99B | 1.04% | 1,046,613 | 43.74M |
| 35 | BLTE | Belite Bio, Inc | 6.79B | 0.66% | 100,154 | - |
| 36 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.66B | -3.28% | 641,647 | 174.33M |
| 37 | MIRM | Mirum Pharmaceuticals, Inc. | 6.30B | -0.31% | 606,134 | 471.79M |
| 38 | COGT | Cogent Biosciences, Inc. | 6.01B | -2.61% | 1,883,498 | - |
| 39 | PTCT | PTC Therapeutics, Inc. | 5.85B | 1.09% | 2,532,064 | 1.73B |
| 40 | CAI | Caris Life Sciences, Inc. | 5.51B | -6.33% | 3,637,334 | 649.06M |
| 41 | IMVT | Immunovant, Inc. | 5.41B | 0.91% | 719,596 | - |
| 42 | PTGX | Protagonist Therapeutics, Inc. | 5.17B | -0.40% | 577,965 | 209.22M |
| 43 | CRSP | CRISPR Therapeutics AG | 5.13B | -2.16% | 1,297,201 | 3.51M |
| 44 | SRRK | Scholar Rock Holding Corporation | 4.90B | 0.63% | 1,252,822 | - |
| 45 | CELC | Celcuity Inc. | 4.85B | -1.86% | 325,388 | - |
| 46 | CGON | CG Oncology, Inc. | 4.65B | 2.14% | 730,132 | 2.17M |
| 47 | APGE | Apogee Therapeutics, Inc. | 4.62B | -0.78% | 920,118 | - |
| 48 | GPCR | Structure Therapeutics Inc. | 4.60B | -1.36% | 940,406 | - |
| 49 | FOLD | Amicus Therapeutics, Inc. | 4.50B | -0.07% | 4,645,854 | 634.21M |
| 50 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.45B | -1.27% | 930,050 | 1.54M |
| 51 | TGTX | TG Therapeutics, Inc. | 4.32B | 0.24% | 1,298,267 | 531.90M |
| 52 | TERN | Terns Pharmaceuticals, Inc. | 4.27B | -0.56% | 1,263,475 | - |
| 53 | NAMS | NewAmsterdam Pharma Company N.V. | 4.09B | 2.74% | 796,235 | 22.50M |
| 54 | ACAD | ACADIA Pharmaceuticals Inc. | 4.06B | -1.40% | 2,246,880 | 1.05B |
| 55 | ERAS | Erasca, Inc. | 3.88B | 1.21% | 2,412,905 | - |
| 56 | ADMA | ADMA Biologics, Inc. | 3.83B | -1.35% | 2,614,679 | 488.56M |
| 57 | ACLX | Arcellx, Inc. | 3.71B | -3.64% | 890,231 | 35.90M |
| 58 | CORT | Corcept Therapeutics Incorporated | 3.66B | 1.69% | 2,559,867 | 741.17M |
| 59 | LGND | Ligand Pharmaceuticals Incorporated | 3.62B | -1.26% | 163,845 | 251.23M |
| 60 | VKTX | Viking Therapeutics, Inc. | 3.59B | -0.23% | 1,786,027 | - |
| 61 | CNTA | Centessa Pharmaceuticals plc | 3.58B | -1.84% | 1,110,580 | 15.00M |
| 62 | ALMS | Alumis Inc. | 3.49B | -4.25% | 1,151,399 | 22.12M |
| 63 | SYRE | Spyre Therapeutics, Inc. | 3.38B | 14.28% | 2,278,268 | - |
| 64 | LEGN | Legend Biotech Corporation | 3.35B | -1.31% | 1,361,875 | 909.05M |
| 65 | XENE | Xenon Pharmaceuticals Inc. | 3.26B | -1.97% | 735,282 | 7.50M |
| 66 | DNLI | Denali Therapeutics Inc. | 3.15B | -0.25% | 1,797,604 | - |
| 67 | ARQT | Arcutis Biotherapeutics, Inc. | 3.11B | -9.07% | 2,716,516 | 317.93M |
| 68 | EWTX | Edgewise Therapeutics, Inc. | 3.10B | -0.68% | 627,581 | - |
| 69 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.99B | -0.49% | 1,274,887 | 578.20M |
| 70 | VERA | Vera Therapeutics, Inc. | 2.96B | -0.93% | 882,491 | - |
| 71 | LQDA | Liquidia Corporation | 2.92B | -4.17% | 1,544,809 | 69.22M |
| 72 | TARS | Tarsus Pharmaceuticals, Inc. | 2.83B | 1.63% | 919,349 | 366.10M |
| 73 | APLS | Apellis Pharmaceuticals, Inc. | 2.82B | -2.28% | 1,506,496 | 1.02B |
| 74 | IDYA | IDEAYA Biosciences, Inc. | 2.81B | -2.80% | 805,692 | 218.71M |
| 75 | TVTX | Travere Therapeutics, Inc. | 2.80B | 3.72% | 1,989,338 | 490.73M |
| 76 | BEAM | Beam Therapeutics Inc. | 2.72B | -1.04% | 1,170,194 | 55.70M |
| 77 | VRDN | Viridian Therapeutics, Inc. | 2.62B | -2.35% | 990,051 | 70.79M |
| 78 | TLX | Telix Pharmaceuticals Limited | 2.50B | 14.61% | 760,156 | 803.79M |
| 79 | WVE | Wave Life Sciences Ltd. | 2.47B | 2.51% | 1,983,053 | 109.23M |
| 80 | DYN | Dyne Therapeutics, Inc. | 2.45B | -2.43% | 1,760,209 | - |
| 81 | IMNM | Immunome, Inc. | 2.37B | -2.89% | 1,080,524 | 9.68M |
| 82 | RCUS | Arcus Biosciences, Inc. | 2.35B | -2.52% | 1,153,491 | 240.00M |
| 83 | ADPT | Adaptive Biotechnologies Corporation | 2.34B | -5.30% | 1,661,315 | 276.98M |
| 84 | IRON | Disc Medicine, Inc. | 2.32B | -3.14% | 920,141 | - |
| 85 | ZLAB | Zai Lab Limited | 2.25B | -0.20% | 519,547 | 441.63M |
| 86 | AAPG | Ascentage Pharma Group International | 2.24B | 2.48% | 1,306 | 54.52M |
| 87 | GLPG | Galapagos NV | 2.23B | -1.20% | 71,265 | 336.64M |
| 88 | MLYS | Mineralys Therapeutics, Inc. | 2.21B | -0.64% | 777,551 | - |
| 89 | MESO | Mesoblast Limited | 2.20B | -0.18% | 168,424 | 17.20M |
| 90 | RARE | Ultragenyx Pharmaceutical Inc. | 2.19B | 4.08% | 2,129,987 | 673.00M |
| 91 | DNTH | Dianthus Therapeutics, Inc. | 2.14B | -0.32% | 388,498 | 3.08M |
| 92 | MAZE | Maze Therapeutics, Inc. | 2.13B | -1.82% | 267,570 | 2.50M |
| 93 | SLNO | Soleno Therapeutics, Inc. | 2.11B | -0.13% | 1,440,134 | 98.68M |
| 94 | NKTR | Nektar Therapeutics | 2.06B | -0.18% | 1,001,018 | 62.60M |
| 95 | SRPT | Sarepta Therapeutics, Inc. | 1.98B | 1.56% | 1,493,945 | 2.41B |
| 96 | STOK | Stoke Therapeutics, Inc. | 1.96B | -0.23% | 874,313 | 205.63M |
| 97 | VCEL | Vericel Corporation | 1.93B | -0.21% | 519,758 | 258.72M |
| 98 | AUPH | Aurinia Pharmaceuticals Inc. | 1.90B | - | 549,686 | 265.81M |
| 99 | OLMA | Olema Pharmaceuticals, Inc. | 1.89B | 1.13% | 1,076,979 | - |
| 100 | NUVB | Nuvation Bio Inc. | 1.87B | -0.73% | 3,774,900 | 26.75M |
| 101 | PHVS | Pharvaris N.V. | 1.83B | 0.36% | 163,411 | - |
| 102 | GLTO | Galecto, Inc. | 1.81B | -1.51% | 105,609 | - |
| 103 | RAPT | RAPT Therapeutics, Inc. | 1.79B | 0.21% | 1,598,541 | - |
| 104 | RXRX | Recursion Pharmaceuticals, Inc. | 1.78B | -8.06% | 18,916,768 | 43.69M |
| 105 | INVA | Innoviva, Inc. | 1.75B | -1.06% | 683,537 | 388.52M |
| 106 | AGIO | Agios Pharmaceuticals, Inc. | 1.71B | 2.34% | 979,152 | 54.03M |
| 107 | SNDX | Syndax Pharmaceuticals, Inc. | 1.71B | -4.56% | 1,722,685 | 111.30M |
| 108 | MNKD | MannKind Corporation | 1.70B | 0.18% | 2,900,525 | 313.79M |
| 109 | ZYME | Zymeworks Inc. | 1.70B | -2.57% | 537,856 | 134.48M |
| 110 | OCUL | Ocular Therapeutix, Inc. | 1.69B | 10.67% | 13,003,422 | 51.95M |
| 111 | DFTX | Definium Therapeutics, Inc. | 1.69B | -0.81% | 1,011,044 | - |
| 112 | OCS | Oculis Holding AG | 1.69B | 2.46% | 362,027 | 992.00K |
| 113 | TYRA | Tyra Biosciences, Inc. | 1.69B | 0.80% | 548,776 | - |
| 114 | HRMY | Harmony Biosciences Holdings, Inc. | 1.68B | -15.21% | 5,447,577 | 825.94M |
| 115 | MANE | Veradermics, Incorporated | 1.66B | -7.93% | 252,936 | - |
| 116 | IMCR | Immunocore Holdings plc | 1.65B | -1.27% | 453,376 | 379.59M |
| 117 | TNGX | Tango Therapeutics, Inc. | 1.64B | -1.21% | 1,646,221 | 66.50M |
| 118 | MBX | MBX Biosciences, Inc. | 1.64B | -6.63% | 452,200 | - |
| 119 | NRIX | Nurix Therapeutics, Inc. | 1.62B | -0.06% | 1,593,596 | 83.98M |
| 120 | SION | Sionna Therapeutics, Inc. | 1.58B | -4.95% | 145,516 | - |
| 121 | KOD | Kodiak Sciences Inc. | 1.57B | -5.21% | 491,711 | - |
| 122 | ORKA | Oruka Therapeutics, Inc. | 1.57B | -0.25% | 394,673 | - |
| 123 | PGEN | Precigen, Inc. | 1.55B | -2.88% | 6,025,832 | 6.31M |
| 124 | ELVN | Enliven Therapeutics, Inc. | 1.54B | -0.54% | 598,143 | - |
| 125 | CLDX | Celldex Therapeutics, Inc. | 1.53B | -2.21% | 448,078 | 2.60M |
| 126 | RLAY | Relay Therapeutics, Inc. | 1.51B | -1.81% | 1,082,838 | 8.36M |
| 127 | GLUE | Monte Rosa Therapeutics, Inc. | 1.50B | -0.94% | 882,745 | 181.54M |
| 128 | ANAB | AnaptysBio, Inc. | 1.50B | -2.29% | 440,362 | 169.47M |
| 129 | NVAX | Novavax, Inc. | 1.49B | -0.33% | 3,416,600 | 1.06B |
| 130 | BHVN | Biohaven Ltd. | 1.49B | -1.40% | 2,118,180 | - |
| 131 | CAPR | Capricor Therapeutics, Inc. | 1.47B | -2.20% | 2,052,480 | 11.13M |
| 132 | NTLA | Intellia Therapeutics, Inc. | 1.46B | -3.07% | 2,522,593 | 57.53M |
| 133 | QURE | uniQure N.V. | 1.46B | -3.98% | 1,630,105 | 15.75M |
| 134 | RAPP | Rapport Therapeutics, Inc. | 1.42B | -0.77% | 392,562 | - |
| 135 | ATAI | AtaiBeckley Inc. | 1.41B | 1.57% | 3,310,499 | 3.02M |
| 136 | ARDX | Ardelyx, Inc. | 1.41B | -14.99% | 14,018,405 | 407.32M |
| 137 | ZBIO | Zenas BioPharma, Inc. | 1.39B | -4.22% | 747,657 | 15.00M |
| 138 | CRVS | Corvus Pharmaceuticals, Inc. | 1.39B | -5.48% | 1,949,874 | - |
| 139 | SVRA | Savara Inc. | 1.37B | -3.32% | 1,022,535 | - |
| 140 | TRVI | Trevi Therapeutics, Inc. | 1.36B | 0.76% | 1,424,483 | - |
| 141 | IMTX | Immatics N.V. | 1.35B | -2.33% | 395,693 | 99.45M |
| 142 | MLTX | MoonLake Immunotherapeutics | 1.34B | 3.30% | 1,983,012 | - |
| 143 | TSHA | Taysha Gene Therapies, Inc. | 1.29B | -1.88% | 1,189,567 | 6.31M |
| 144 | EYPT | EyePoint, Inc. | 1.27B | 4.29% | 1,074,179 | 42.34M |
| 145 | DBVT | DBV Technologies S.A. | 1.27B | 1.59% | 75,820 | 5.50M |
| 146 | IVA | Inventiva S.A. | 1.26B | 0.90% | 667,834 | 19.93M |
| 147 | NBTX | Nanobiotix S.A. | 1.24B | -5.74% | 37,128 | 11.93M |
| 148 | SEPN | Septerna, Inc. | 1.22B | 0.74% | 293,621 | 22.05M |
| 149 | DAWN | Day One Biopharmaceuticals, Inc. | 1.21B | -2.40% | 1,369,644 | 133.67M |
| 150 | GERN | Geron Corporation | 1.20B | -2.08% | 25,231,717 | 183.40M |
| 151 | INBX | Inhibrx Biosciences, Inc. | 1.14B | -3.01% | 81,639 | 1.40M |
| 152 | IOVA | Iovance Biotherapeutics, Inc. | 1.14B | 0.70% | 9,186,959 | 250.43M |
| 153 | PHAR | Pharming Group N.V. | 1.14B | -0.67% | 11,198 | 362.27M |
| 154 | CMPX | Compass Therapeutics, Inc. | 1.10B | -3.44% | 1,358,911 | 850.00K |
| 155 | XERS | Xeris Biopharma Holdings, Inc. | 1.10B | -1.78% | 2,164,971 | 266.14M |
| 156 | ORIC | ORIC Pharmaceuticals, Inc. | 1.08B | -1.94% | 1,110,497 | - |
| 157 | SANA | Sana Biotechnology, Inc. | 1.07B | -3.14% | 1,846,024 | - |
| 158 | VIR | Vir Biotechnology, Inc. | 1.05B | -3.32% | 1,065,589 | 16.86M |
| 159 | FTRE | Fortrea Holdings Inc. | 1.02B | -0.09% | 2,086,782 | 2.76B |
| 160 | PVLA | Palvella Therapeutics, Inc. | 1.01B | 4.04% | 277,357 | - |
| 161 | VTYX | Ventyx Biosciences, Inc. | 1.00B | 0.07% | 3,693,496 | - |
| 162 | TBPH | Theravance Biopharma, Inc. | 996.22M | 1.18% | 630,629 | 80.33M |
| 163 | AKTS | Aktis Oncology, Inc. | 992.67M | 2.66% | 249,933 | 5.56M |
| 164 | URGN | UroGen Pharma Ltd. | 986.26M | -3.35% | 579,125 | 96.52M |
| 165 | SGP | SpyGlass Pharma, Inc. | 976.87M | -1.21% | 41,423 | - |
| 166 | VALN | Valneva SE | 972.35M | 4.67% | 41,036 | 211.09M |
| 167 | GHRS | GH Research PLC | 967.35M | -1.30% | 110,985 | - |
| 168 | AVBP | ArriVent BioPharma, Inc. | 949.06M | -0.43% | 300,734 | - |
| 169 | CTMX | CytomX Therapeutics, Inc. | 920.03M | -0.73% | 1,907,189 | 113.63M |
| 170 | ABCL | AbCellera Biologics Inc. | 909.98M | -5.59% | 4,703,134 | 35.33M |
| 171 | PHAT | Phathom Pharmaceuticals, Inc. | 894.13M | -4.67% | 1,455,018 | 147.19M |
| 172 | EVMN | Evommune, Inc. | 892.45M | -1.46% | 389,469 | 13.00M |
| 173 | SPRY | ARS Pharmaceuticals, Inc. | 889.64M | -4.66% | 892,457 | 142.77M |
| 174 | OMER | Omeros Corporation | 853.64M | 0.25% | 1,007,375 | - |
| 175 | BCAX | Bicara Therapeutics Inc. | 848.02M | 0.39% | 1,177,706 | - |
| 176 | DRUG | Bright Minds Biosciences Inc. | 843.56M | -0.70% | 87,472 | - |
| 177 | ABUS | Arbutus Biopharma Corporation | 821.22M | 0.71% | 1,330,359 | 14.61M |
| 178 | XNCR | Xencor, Inc. | 814.79M | -2.81% | 487,467 | 150.13M |
| 179 | CGEM | Cullinan Therapeutics, Inc. | 806.39M | -1.66% | 930,213 | - |
| 180 | EIKN | Eikon Therapeutics, Inc. | 803.29M | -4.00% | 285,480 | - |
| 181 | KALV | KalVista Pharmaceuticals, Inc. | 800.15M | -0.38% | 352,434 | 1.43M |
| 182 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 798.29M | -1.38% | 205,738 | - |
| 183 | MRVI | Maravai LifeSciences Holdings, Inc. | 792.69M | 0.65% | 649,139 | 192.44M |
| 184 | JANX | Janux Therapeutics, Inc. | 786.73M | -2.53% | 813,596 | 10.00M |
| 185 | MPLT | MapLight Therapeutics, Inc. | 780.31M | -0.22% | 121,015 | - |
| 186 | ARVN | Arvinas, Inc. | 770.05M | -3.62% | 860,242 | 312.30M |
| 187 | MDXG | MiMedx Group, Inc. | 765.69M | -0.58% | 794,067 | 393.44M |
| 188 | AGMB | AgomAb Therapeutics NV | 755.42M | -0.70% | 67,239 | - |
| 189 | GYRE | Gyre Therapeutics, Inc. | 752.57M | -1.66% | 75,560 | 107.27M |
| 190 | KURA | Kura Oncology, Inc. | 736.17M | -1.40% | 1,562,223 | 104.03M |
| 191 | ANNX | Annexon, Inc. | 730.37M | -3.92% | 1,749,100 | - |
| 192 | FULC | Fulcrum Therapeutics, Inc. | 725.67M | -6.22% | 833,728 | 80.00M |
| 193 | REPL | Replimune Group, Inc. | 713.43M | 1.05% | 1,577,690 | - |
| 194 | SLS | SELLAS Life Sciences Group, Inc. | 706.67M | 2.72% | 5,943,598 | - |
| 195 | ENGN | enGene Holdings Inc. | 693.96M | -2.07% | 85,340 | - |
| 196 | JBIO | Jade Biosciences, Inc. | 656.48M | -1.92% | 265,078 | - |
| 197 | RIGL | Rigel Pharmaceuticals, Inc. | 643.65M | -3.22% | 354,529 | 282.08M |
| 198 | PROK | ProKidney Corp. | 628.74M | -4.57% | 399,256 | 744.00K |
| 199 | LXRX | Lexicon Pharmaceuticals, Inc. | 627.81M | -3.29% | 2,257,179 | 70.86M |
| 200 | DRTS | Alpha Tau Medical Ltd. | 624.13M | 1.10% | 243,446 | - |
| 201 | MGTX | MeiraGTx Holdings plc | 599.66M | -1.19% | 303,874 | 27.42M |
| 202 | LBRX | LB Pharmaceuticals Inc | 599.59M | -2.07% | 183,685 | - |
| 203 | PRME | Prime Medicine, Inc. | 578.91M | -1.80% | 1,673,807 | 5.98M |
| 204 | NMRA | Neumora Therapeutics, Inc. | 576.09M | -2.59% | 721,553 | - |
| 205 | DSGN | Design Therapeutics, Inc. | 575.90M | -1.65% | 172,544 | - |
| 206 | CTNM | Contineum Therapeutics, Inc. | 569.13M | -2.62% | 117,658 | - |
| 207 | YDES | YD Bio Limited | 564.11M | -5.68% | 15,536 | 510.36K |
| 208 | VOR | Vor Biopharma Inc. | 562.59M | 1.80% | 423,915 | - |
| 209 | CRMD | CorMedix Inc. | 553.89M | -0.71% | 2,061,142 | 214.30M |
| 210 | ALT | Altimmune, Inc. | 548.51M | -2.45% | 4,136,447 | 20.00K |
| 211 | ANRO | Alto Neuroscience, Inc. | 547.39M | -9.64% | 184,403 | - |
| 212 | OCGN | Ocugen, Inc. | 524.62M | 0.63% | 6,163,347 | 5.37M |
| 213 | DNA | Ginkgo Bioworks Holdings, Inc. | 524.03M | -4.85% | 642,239 | 180.61M |
| 214 | FBRX | Forte Biosciences, Inc. | 517.83M | -2.12% | 160,367 | - |
| 215 | EPRX | Eupraxia Pharmaceuticals Inc. | 512.87M | 4.68% | 612,685 | - |
| 216 | ADCT | ADC Therapeutics SA | 507.90M | -2.84% | 648,165 | 75.21M |
| 217 | TENX | Tenax Therapeutics, Inc. | 497.39M | -1.37% | 77,524 | - |
| 218 | ZVRA | Zevra Therapeutics, Inc. | 495.42M | -1.01% | 593,971 | 84.39M |
| 219 | KROS | Keros Therapeutics, Inc. | 493.55M | -2.11% | 468,646 | 246.72M |
| 220 | GOSS | Gossamer Bio, Inc. | 493.00M | 0.95% | 8,452,411 | 44.05M |
| 221 | PRTA | Prothena Corporation plc | 485.55M | -0.11% | 786,409 | 9.68M |
| 222 | ALLO | Allogene Therapeutics, Inc. | 460.70M | -3.76% | 4,097,490 | 22.00K |
| 223 | FDMT | 4D Molecular Therapeutics, Inc. | 460.09M | -1.64% | 657,417 | 120.00K |
| 224 | LXEO | Lexeo Therapeutics, Inc. | 459.09M | 0.32% | 659,383 | - |
| 225 | VSTM | Verastem, Inc. | 457.69M | -0.17% | 2,012,479 | 13.38M |
| 226 | ZURA | Zura Bio Limited | 456.82M | -1.27% | 226,456 | - |
| 227 | ASMB | Assembly Biosciences, Inc. | 454.74M | 10.70% | 142,905 | 37.19M |
| 228 | LYEL | Lyell Immunopharma, Inc. | 454.62M | -0.93% | 74,820 | 41.00K |
| 229 | DMAC | DiaMedica Therapeutics Inc. | 451.13M | -0.94% | 180,606 | - |
| 230 | SLDB | Solid Biosciences Inc. | 444.87M | -2.89% | 675,125 | - |
| 231 | AUTL | Autolus Therapeutics plc | 444.46M | 1.83% | 2,205,390 | 51.13M |
| 232 | KYTX | Kyverna Therapeutics, Inc. | 438.75M | -5.19% | 412,554 | - |
| 233 | LCTX | Lineage Cell Therapeutics, Inc. | 438.61M | 1.69% | 1,034,030 | 10.82M |
| 234 | IVVD | Invivyd, Inc. | 437.08M | -3.73% | 1,908,173 | 50.04M |
| 235 | UPB | Upstream Bio, Inc. | 436.63M | -5.39% | 3,597,516 | 2.80M |
| 236 | PEPG | PepGen Inc. | 427.61M | -6.61% | 317,491 | - |
| 237 | VTVT | vTv Therapeutics Inc. | 425.62M | -2.86% | 17,826 | 17.00K |
| 238 | IMMX | Immix Biopharma, Inc. | 421.56M | 2.43% | 511,549 | - |
| 239 | PRTC | PureTech Health plc | 414.12M | -2.60% | 1,712 | 6.39M |
| 240 | RGNX | REGENXBIO Inc. | 412.07M | -3.21% | 1,019,235 | 161.32M |
| 241 | IMMP | Immutep Limited | 411.60M | -2.45% | 63,349 | 3.31M |
| 242 | RCKT | Rocket Pharmaceuticals, Inc. | 409.08M | 1.07% | 2,481,280 | - |
| 243 | TRDA | Entrada Therapeutics, Inc. | 404.88M | -1.05% | 184,098 | 61.52M |
| 244 | TECX | Tectonic Therapeutic, Inc. | 399.97M | 1.76% | 248,955 | - |
| 245 | ABSI | Absci Corporation | 398.48M | -4.68% | 2,492,075 | 2.82M |
| 246 | ENTA | Enanta Pharmaceuticals, Inc. | 392.05M | -3.50% | 435,611 | 66.98M |
| 247 | NAGE | Niagen Bioscience, Inc. | 389.23M | -1.62% | 972,230 | 124.71M |
| 248 | AVXL | Anavex Life Sciences Corp. | 381.81M | - | 800,557 | - |
| 249 | NBP | NovaBridge Biosciences | 379.31M | -0.90% | 249,446 | - |
| 250 | CADL | Candel Therapeutics, Inc. | 373.93M | -14.20% | 7,804,221 | - |
| 251 | BCYC | Bicycle Therapeutics plc | 372.51M | -3.07% | 282,465 | 28.34M |
| 252 | MNPR | Monopar Therapeutics Inc. | 370.28M | 1.30% | 192,978 | - |
| 253 | IPSC | Century Therapeutics, Inc. | 370.07M | -3.74% | 494,152 | 113.34M |
| 254 | TARA | Protara Therapeutics, Inc. | 366.54M | -4.34% | 1,116,405 | - |
| 255 | ANL | Adlai Nortye Ltd. | 366.05M | 0.61% | 293,122 | -1.35M |
| 256 | BNTC | Benitec Biopharma Inc. | 364.47M | -1.85% | 106,596 | - |
| 257 | AVIR | Atea Pharmaceuticals, Inc. | 363.29M | -1.90% | 487,510 | - |
| 258 | LENZ | LENZ Therapeutics, Inc. | 362.65M | -3.82% | 658,892 | 17.50M |
| 259 | NAUT | Nautilus Biotechnology, Inc. | 356.18M | -2.42% | 171,193 | - |
| 260 | ACRS | Aclaris Therapeutics, Inc. | 351.04M | 0.31% | 1,381,289 | 15.74M |
| 261 | PBYI | Puma Biotechnology, Inc. | 344.17M | 0.59% | 253,990 | 212.00M |
| 262 | AURA | Aura Biosciences, Inc. | 343.55M | 0.93% | 234,936 | - |
| 263 | RZLT | Rezolute, Inc. | 341.74M | 0.30% | 1,339,108 | - |
| 264 | HELP | Cybin Inc. | 340.74M | -1.30% | 395,805 | - |
| 265 | VNDA | Vanda Pharmaceuticals Inc. | 340.46M | -5.57% | 6,210,468 | 216.11M |
| 266 | FHTX | Foghorn Therapeutics Inc. | 335.67M | -1.72% | 92,687 | 24.52M |
| 267 | GLSI | Greenwich LifeSciences, Inc. | 333.34M | -3.49% | 99,986 | - |
| 268 | IMRX | Immuneering Corporation | 322.85M | -4.76% | 689,699 | - |
| 269 | ALXO | ALX Oncology Holdings Inc. | 321.43M | -5.77% | 498,222 | - |
| 270 | XOMA | XOMA Royalty Corporation | 319.61M | 5.78% | 240,872 | 47.11M |
| 271 | ARMP | Armata Pharmaceuticals, Inc. | 317.83M | 4.05% | 46,207 | 5.05M |
| 272 | RLMD | Relmada Therapeutics, Inc. | 302.87M | -5.28% | 705,347 | - |
| 273 | STRO | Sutro Biopharma, Inc. | 301.86M | -5.83% | 122,010 | 105.65M |
| 274 | FENC | Fennec Pharmaceuticals Inc. | 298.50M | -0.46% | 75,416 | 38.79M |
| 275 | ALDX | Aldeyra Therapeutics, Inc. | 297.81M | -2.56% | 483,370 | - |
| 276 | CLLS | Cellectis S.A. | 293.12M | -2.26% | 10,398 | 82.55M |
| 277 | ABEO | Abeona Therapeutics Inc. | 285.05M | -0.57% | 714,512 | 400.00K |
| 278 | CABA | Cabaletta Bio, Inc. | 280.13M | -7.32% | 3,304,303 | - |
| 279 | XFOR | X4 Pharmaceuticals, Inc. | 276.30M | 1.94% | 322,195 | 33.98M |
| 280 | NGNE | Neurogene Inc. | 273.24M | -5.26% | 179,402 | 925.00K |
| 281 | NERV | Minerva Neurosciences, Inc. | 273.06M | -0.47% | 75,449 | - |
| 282 | CLYM | Climb Bio, Inc. | 268.80M | -0.18% | 700,912 | - |
| 283 | AARD | Aardvark Therapeutics, Inc. | 268.25M | -0.73% | 51,213 | - |
| 284 | AVTX | Avalo Therapeutics, Inc. | 263.07M | -11.02% | 430,806 | 192.00K |
| 285 | LRMR | Larimar Therapeutics, Inc. | 254.20M | -4.50% | 873,375 | - |
| 286 | STTK | Shattuck Labs, Inc. | 253.75M | -1.47% | 272,534 | 1.00M |
| 287 | ACIU | AC Immune SA | 249.34M | -0.40% | 279,719 | 5.48M |
| 288 | PLX | Protalix BioTherapeutics, Inc. | 246.09M | -2.86% | 1,334,260 | 61.84M |
| 289 | OABI | OmniAb, Inc. | 244.72M | -0.58% | 152,188 | 21.09M |
| 290 | CHRS | Coherus Oncology, Inc. | 243.64M | -4.68% | 1,368,482 | 277.73M |
| 291 | IKT | Inhibikase Therapeutics, Inc. | 240.74M | 1.15% | 673,731 | 1.00 |
| 292 | ENLV | Enlivex Therapeutics Ltd. | 239.76M | -3.81% | 66,677 | - |
| 293 | PALI | Palisade Bio, Inc. | 238.41M | -1.84% | 2,261,577 | - |
| 294 | SLN | Silence Therapeutics plc | 236.17M | - | 95,928 | 25.83M |
| 295 | SLGL | Sol-Gel Technologies Ltd. | 233.95M | 3.87% | 9,845 | 18.97M |
| 296 | IRD | Opus Genetics, Inc. | 233.79M | -5.04% | 788,732 | 14.63M |
| 297 | PRLD | Prelude Therapeutics Incorporated | 229.06M | 22.47% | 831,787 | 10.50M |
| 298 | MDWD | MediWound Ltd. | 229.01M | 3.47% | 81,778 | 20.93M |
| 299 | SRZN | Surrozen, Inc. | 227.91M | -1.26% | 42,353 | 3.60M |
| 300 | CBIO | Crescent Biopharma, Inc. | 227.75M | -1.19% | 153,709 | - |
| 301 | ACHV | Achieve Life Sciences, Inc. | 227.31M | -2.29% | 434,982 | - |
| 302 | CAMP | Camp4 Therapeutics Corporation | 225.16M | -2.47% | 69,050 | 3.80M |
| 303 | NVCT | Nuvectis Pharma, Inc. | 224.12M | -0.59% | 43,162 | - |
| 304 | OBIO | Orchestra BioMed Holdings, Inc. | 221.34M | -1.38% | 718,342 | 2.82M |
| 305 | HUMA | Humacyte, Inc. | 218.09M | -1.74% | 3,089,049 | 1.57M |
| 306 | ARCT | Arcturus Therapeutics Holdings Inc. | 217.94M | -3.76% | 409,681 | 97.60M |
| 307 | ALEC | Alector, Inc. | 217.21M | -1.00% | 486,439 | 69.05M |
| 308 | HRTX | Heron Therapeutics, Inc. | 216.37M | -0.84% | 839,116 | 155.10M |
| 309 | CCCC | C4 Therapeutics, Inc. | 209.34M | 1.89% | 1,145,405 | 30.11M |
| 310 | CNTX | Context Therapeutics Inc. | 205.81M | -3.45% | 539,950 | - |
| 311 | CBUS | Cibus, Inc. | 201.99M | 0.34% | 664,271 | 3.79M |
| 312 | VYGR | Voyager Therapeutics, Inc. | 194.04M | 2.05% | 396,627 | 31.32M |
| 313 | NTHI | NeOnc Technologies Holdings, Inc. | 193.77M | 16.86% | 53,417 | 59.99K |
| 314 | GALT | Galectin Therapeutics Inc. | 191.48M | 1.37% | 156,726 | - |
| 315 | OVID | Ovid Therapeutics Inc. | 191.37M | -3.29% | 602,336 | 6.61M |
| 316 | KLRS | Kalaris Therapeutics, Inc. | 187.02M | -8.93% | 81,276 | - |
| 317 | CNTN | Canton Strategic Holdings, Inc. | 185.00M | 3.77% | 798,573 | - |
| 318 | RNAC | Cartesian Therapeutics, Inc. | 180.20M | 2.21% | 100,500 | 1.09M |
| 319 | TNXP | Tonix Pharmaceuticals Holding Corp. | 179.63M | -8.24% | 722,520 | 10.30M |
| 320 | MOLN | Molecular Partners AG | 178.48M | -2.00% | 488 | 856.30K |
| 321 | KPTI | Karyopharm Therapeutics Inc. | 177.39M | - | 312,542 | 146.07M |
| 322 | EDIT | Editas Medicine, Inc. | 174.74M | -1.10% | 1,534,246 | 46.38M |
| 323 | ELDN | Eledon Pharmaceuticals, Inc. | 173.78M | -1.35% | 1,099,173 | - |
| 324 | SGMT | Sagimet Biosciences Inc. | 173.01M | -1.12% | 397,013 | - |
| 325 | MIST | Milestone Pharmaceuticals Inc. | 172.69M | 1.19% | 1,517,393 | - |
| 326 | SABS | SAB Biotherapeutics, Inc. | 169.96M | -5.80% | 123,874 | 114.70K |
| 327 | FATE | Fate Therapeutics, Inc. | 168.41M | 4.29% | 1,976,641 | 7.14M |
| 328 | CRBU | Caribou Biosciences, Inc. | 168.24M | 2.27% | 1,762,751 | 9.30M |
| 329 | NKTX | Nkarta, Inc. | 165.50M | -1.27% | 531,501 | - |
| 330 | TLSA | Tiziana Life Sciences Ltd | 163.36M | -8.57% | 92,511 | - |
| 331 | CGEN | Compugen Ltd. | 162.75M | -2.79% | 150,356 | 6.90M |
| 332 | RANI | Rani Therapeutics Holdings, Inc. | 156.76M | -3.01% | 695,959 | 1.20M |
| 333 | ZNTL | Zentalis Pharmaceuticals, Inc. | 156.70M | -3.97% | 1,328,849 | 26.87M |
| 334 | ABOS | Acumen Pharmaceuticals, Inc. | 155.67M | -5.51% | 221,470 | - |
| 335 | IPHA | Innate Pharma S.A. | 155.25M | -4.14% | 29,947 | 14.84M |
| 336 | MENS | Jyong Biotech Ltd. | 154.57M | 1.01% | 187,253 | - |
| 337 | ELTX | Elicio Therapeutics, Inc. | 152.91M | -1.24% | 48,576 | - |
| 338 | PRQR | ProQR Therapeutics N.V. | 151.70M | -2.04% | 249,633 | 18.86M |
| 339 | CNTB | Connect Biopharma Holdings Limited | 148.14M | -8.62% | 81,285 | 762.00K |
| 340 | ADAG | Adagene Inc. | 147.99M | -3.09% | 64,056 | 103.20K |
| 341 | PMN | ProMIS Neurosciences, Inc. | 144.29M | -0.43% | 33,120 | - |
| 342 | WHWK | Whitehawk Therapeutics, Inc. | 143.74M | 0.69% | 67,053 | 14.38M |
| 343 | SGMO | Sangamo Therapeutics, Inc. | 143.02M | 1.29% | 5,089,979 | 32.88M |
| 344 | VXRT | Vaxart, Inc. | 140.15M | 4.85% | - | 148.20M |
| 345 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 137.48M | -3.39% | 101,664 | - |
| 346 | UNCY | Unicycive Therapeutics, Inc. | 134.97M | -3.53% | 345,205 | - |
| 347 | TNYA | Tenaya Therapeutics, Inc. | 134.08M | -1.70% | 4,563,917 | - |
| 348 | BDTX | Black Diamond Therapeutics, Inc. | 132.75M | 1.30% | 482,281 | 70.00M |
| 349 | SPRO | Spero Therapeutics, Inc. | 129.58M | -4.17% | 159,081 | 40.55M |
| 350 | ORMP | Oramed Pharmaceuticals Inc. | 128.16M | 1.58% | 102,133 | 2.00M |
| 351 | ACOG | Alpha Cognition Inc. | 127.19M | - | 27,654 | 7.43M |
| 352 | PLYX | Polaryx Therapeutics, Inc. | 123.57M | -2.25% | 611,954 | - |
| 353 | IMUX | Immunic, Inc. | 122.64M | -3.56% | 2,541,431 | - |
| 354 | INO | Inovio Pharmaceuticals, Inc. | 118.86M | 0.58% | 965,069 | 182.34K |
| 355 | GNLX | Genelux Corporation | 116.91M | -1.49% | 86,963 | 8.00K |
| 356 | ARTV | Artiva Biotherapeutics, Inc. | 114.87M | 3.31% | 129,580 | 251.00K |
| 357 | SEER | Seer, Inc. | 111.38M | -4.35% | 979,922 | 16.38M |
| 358 | CRDF | Cardiff Oncology, Inc. | 108.45M | -1.23% | 440,193 | 501.00K |
| 359 | COYA | Coya Therapeutics, Inc. | 108.09M | -4.95% | 103,818 | 3.99M |
| 360 | MGNX | MacroGenics, Inc. | 107.54M | -1.45% | 197,745 | 127.63M |
| 361 | EQ | Equillium, Inc. | 105.95M | -4.40% | 221,273 | 4.39M |
| 362 | CDXS | Codexis, Inc. | 105.68M | -0.85% | 1,751,410 | 52.93M |
| 363 | KRRO | Korro Bio, Inc. | 104.63M | -5.04% | 129,642 | 7.37M |
| 364 | FBIO | Fortress Biotech, Inc. | 104.29M | -3.45% | 291,765 | 62.30M |
| 365 | AGEN | Agenus Inc. | 104.07M | -4.67% | 400,368 | 106.83M |
| 366 | VANI | Vivani Medical, Inc. | 103.81M | - | 402,490 | - |
| 367 | ONCY | Oncolytics Biotech Inc. | 103.73M | -3.60% | 804,738 | - |
| 368 | SAVA | Cassava Sciences, Inc. | 102.90M | -1.84% | 758,425 | - |
| 369 | TTRX | Turn Therapeutics Inc. | 102.76M | 2.65% | 3,723 | - |
| 370 | ATYR | aTyr Pharma, Inc. | 101.91M | -0.95% | 1,527,408 | 190.00K |
| 371 | DWTX | Dogwood Therapeutics, Inc. | 97.56M | 0.69% | 16,224 | - |
| 372 | ANIX | Anixa Biosciences, Inc. | 96.13M | -1.37% | 95,076 | - |
| 373 | ACTU | Actuate Therapeutics, Inc. | 95.99M | -2.59% | 52,381 | - |
| 374 | BMEA | Biomea Fusion, Inc. | 93.33M | - | 758,835 | - |
| 375 | VRCA | Verrica Pharmaceuticals Inc. | 92.58M | -8.10% | 71,463 | 30.83M |
| 376 | CGTX | Cognition Therapeutics, Inc. | 91.81M | -4.59% | 477,194 | - |
| 377 | DTIL | Precision BioSciences, Inc. | 91.23M | -3.32% | 90,562 | 698.00K |
| 378 | PYXS | Pyxis Oncology, Inc. | 88.42M | -7.19% | 238,206 | 2.82M |
| 379 | OKYO | OKYO Pharma Limited | 87.33M | -3.41% | 259,856 | - |
| 380 | IBIO | iBio, Inc. | 82.21M | -2.86% | 446,933 | 300.00K |
| 381 | CSBR | Champions Oncology, Inc. | 80.82M | -3.80% | 3,923 | 58.42M |
| 382 | MAIA | MAIA Biotechnology, Inc. | 79.59M | - | 259,743 | - |
| 383 | NBY | NovaBay Pharmaceuticals, Inc. | 78.53M | 17.88% | 7,961,904 | 10.30M |
| 384 | MCRB | Seres Therapeutics, Inc. | 77.35M | -2.17% | 69,607 | 351.00K |
| 385 | PLRX | Pliant Therapeutics, Inc. | 76.20M | -4.62% | 529,188 | - |
| 386 | PYPD | PolyPid Ltd. | 76.09M | -2.11% | 54,442 | - |
| 387 | PTHS | Pelthos Therapeutics Inc. | 75.19M | 5.02% | 3,601 | 7.41M |
| 388 | EXOZ | eXoZymes, Inc. | 74.76M | -6.54% | 6,562 | -700.00 |
| 389 | GANX | Gain Therapeutics, Inc. | 74.62M | 2.65% | 464,857 | - |
| 390 | IMA | ImageneBio, Inc. | 74.56M | 4.63% | 134,324 | 800.00K |
| 391 | MNOV | MediciNova, Inc. | 73.72M | -3.23% | 25,201 | 409.66K |
| 392 | ACET | Adicet Bio, Inc. | 72.16M | -4.03% | 202,053 | - |
| 393 | GUTS | Fractyl Health, Inc. | 71.82M | 1.45% | 2,913,651 | 3.00K |
| 394 | XBIT | XBiotech Inc. | 70.43M | -2.94% | 22,771 | - |
| 395 | HURA | TuHURA Biosciences, Inc. | 69.83M | 3.60% | 1,317,126 | - |
| 396 | ETHZ | ETHZilla Corporation | 68.63M | -1.37% | 212,175 | 4.11M |
| 397 | MREO | Mereo BioPharma Group plc | 67.46M | -1.87% | 2,452,914 | 500.00K |
| 398 | ENTX | Entera Bio Ltd. | 67.41M | 3.52% | 88,227 | 124.00K |
| 399 | KZIA | Kazia Therapeutics Limited | 66.85M | -2.00% | 116,263 | 1.20M |
| 400 | ANVS | Annovis Bio, Inc. | 65.73M | 2.90% | 348,981 | - |
| 401 | QTTB | Q32 Bio Inc. | 65.52M | 9.84% | 226,602 | - |
| 402 | COEP | Coeptis Therapeutics Holdings, Inc. | 65.26M | -0.69% | 20,261 | 501.00K |
| 403 | TIL | Instil Bio, Inc. | 62.12M | -1.68% | 61,287 | - |
| 404 | ATHE | Alterity Therapeutics Limited | 61.52M | -2.02% | 3,404 | 3.57M |
| 405 | CING | Cingulate Inc. | 61.36M | -2.64% | 207,559 | - |
| 406 | HYFT | MindWalk Holdings Corp. | 61.17M | -5.76% | 282,780 | 19.02M |
| 407 | IFRX | InflaRx N.V. | 60.61M | 2.51% | 119,554 | 73.73K |
| 408 | GRCE | Grace Therapeutics, Inc. | 60.04M | -0.51% | 611,365 | - |
| 409 | NRXS | NeurAxis, Inc. | 58.91M | 3.36% | 109,995 | 3.36M |
| 410 | ICCC | ImmuCell Corporation | 58.07M | -3.75% | 29,616 | 27.77M |
| 411 | TCRX | TScan Therapeutics, Inc. | 57.32M | -0.98% | 169,912 | 8.42M |
| 412 | TVGN | Tevogen Bio Holdings Inc. | 56.59M | -6.09% | 330,038 | - |
| 413 | PMVP | PMV Pharmaceuticals, Inc. | 55.34M | -1.89% | 118,433 | - |
| 414 | RADX | Radiopharm Theranostics Limited | 55.13M | -0.80% | 34,546 | 8.20M |
| 415 | MGX | Metagenomi Therapeutics, Inc. | 54.82M | -3.95% | 136,337 | 30.91M |
| 416 | NRXP | NRx Pharmaceuticals, Inc. | 54.47M | - | 794,257 | 242.00K |
| 417 | LPCN | Lipocine Inc. | 54.41M | 4.59% | 86,013 | 4.32M |
| 418 | NTRB | Nutriband Inc. | 53.85M | 1.55% | 9,564 | 2.28M |
| 419 | BYSI | BeyondSpring Inc. | 53.46M | -1.52% | 35,360 | 1.88M |
| 420 | INKT | MiNK Therapeutics, Inc. | 53.37M | 1.61% | 6,366 | - |
| 421 | SPRB | Spruce Biosciences, Inc. | 53.22M | -5.51% | 41,489 | 697.00K |
| 422 | LONA | LeonaBio, Inc. | 51.91M | 0.54% | 40,419 | - |
| 423 | KZR | Kezar Life Sciences, Inc. | 50.02M | 1.94% | 52,829 | - |
| 424 | ESLA | Estrella Immunopharma, Inc. | 49.60M | -4.07% | 37,463 | - |
| 425 | PSTV | Plus Therapeutics, Inc. | 48.65M | -6.08% | 3,727,193 | 5.26M |
| 426 | ACRV | Acrivon Therapeutics, Inc. | 48.28M | -3.16% | 511,419 | - |
| 427 | NXTC | NextCure, Inc. | 48.13M | -1.51% | 24,689 | - |
| 428 | IBO | Impact BioMedical Inc. | 46.03M | 6.02% | 125,084 | 25.00K |
| 429 | CRVO | CervoMed Inc. | 42.84M | -11.47% | 77,382 | 6.16M |
| 430 | APLM | Apollomics, Inc. | 42.77M | -1.97% | 16,149 | 6.93M |
| 431 | SNSE | Sensei Biotherapeutics, Inc. | 42.39M | 23.07% | 479,195 | - |
| 432 | ALGS | Aligos Therapeutics, Inc. | 41.84M | -4.49% | 16,246 | 2.65M |
| 433 | XLO | Xilio Therapeutics, Inc. | 41.74M | -0.32% | 87,500 | 31.80M |
| 434 | OSTX | OS Therapies Incorporated | 41.55M | -1.67% | 200,046 | - |
| 435 | LITS | Lite Strategy, Inc. | 40.36M | 0.91% | 301,354 | - |
| 436 | VERU | Veru Inc. | 40.13M | 0.40% | 49,966 | 16.89M |
| 437 | LSTA | Lisata Therapeutics, Inc. | 39.52M | -0.88% | 51,019 | 1.07M |
| 438 | TELO | Telomir Pharmaceuticals, Inc. | 39.19M | 0.88% | 126,084 | - |
| 439 | CELU | Celularity Inc. | 38.93M | 0.75% | 13,796 | 40.58M |
| 440 | CVM | CEL-SCI Corporation | 38.85M | -0.83% | 61,122 | - |
| 441 | ABVC | ABVC BioPharma, Inc. | 37.29M | -0.66% | 35,649 | 797.92K |
| 442 | JSPR | Jasper Therapeutics, Inc. | 36.94M | -5.71% | 208,509 | - |
| 443 | PLUR | Pluri Inc. | 36.79M | -0.54% | 2,519 | 1.34M |
| 444 | ATOS | Atossa Therapeutics, Inc. | 36.25M | -4.75% | 43,942 | - |
| 445 | PDSB | PDS Biotechnology Corporation | 35.46M | -1.49% | 1,212,272 | - |
| 446 | OKUR | OnKure Therapeutics, Inc. | 35.23M | -1.52% | 69,362 | - |
| 447 | PTN | Palatin Technologies, Inc. | 35.14M | 6.95% | 28,124 | 8.96M |
| 448 | INMB | INmune Bio Inc. | 34.83M | -0.76% | 356,641 | 50.00K |
| 449 | OTLK | Outlook Therapeutics, Inc. | 34.32M | -4.95% | 1,133,770 | 205.70K |
| 450 | TVRD | Tvardi Therapeutics, Inc. | 34.15M | 1.39% | 38,544 | - |
| 451 | KYNB | Kyntra Bio, Inc. | 33.66M | 10.08% | 51,687 | 8.30M |
| 452 | RNXT | RenovoRx, Inc. | 33.45M | -2.95% | 96,983 | 928.00K |
| 453 | ATNM | Actinium Pharmaceuticals, Inc. | 33.07M | -4.50% | 87,329 | 90.00K |
| 454 | HOWL | Werewolf Therapeutics, Inc. | 32.53M | -6.81% | 390,967 | 1.14M |
| 455 | TPST | Tempest Therapeutics, Inc. | 32.35M | -1.23% | 40,258 | - |
| 456 | RNTX | Rein Therapeutics Inc. | 31.81M | 8.04% | 81,558 | - |
| 457 | AEON | AEON Biopharma, Inc. | 30.36M | - | 40,799 | - |
| 458 | NRSN | NeuroSense Therapeutics Ltd. | 30.19M | 2.68% | 145,056 | - |
| 459 | ATRA | Atara Biotherapeutics, Inc. | 30.14M | -1.42% | 55,490 | 151.93M |
| 460 | LTRN | Lantern Pharma Inc. | 29.19M | -5.78% | 61,675 | - |
| 461 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 28.86M | -2.95% | 1,669,847 | - |
| 462 | DYAI | Dyadic International, Inc. | 28.77M | -0.86% | 4,862 | 3.34M |
| 463 | BCTX | BriaCell Therapeutics Corp. | 28.65M | -5.08% | 146,186 | - |
| 464 | ANTX | AN2 Therapeutics, Inc. | 28.50M | -4.59% | 101,429 | - |
| 465 | HYPD | Hyperion DeFi, Inc. | 27.63M | -1.20% | 192,701 | 345.32K |
| 466 | EVAX | Evaxion A/S | 27.44M | -5.17% | 12,154 | 7.65M |
| 467 | PASG | Passage Bio, Inc. | 27.37M | -4.44% | 26,712 | - |
| 468 | RLYB | Rallybio Corporation | 26.72M | 6.53% | 110,037 | 674.00K |
| 469 | LIXT | Lixte Biotechnology Holdings, Inc. | 26.49M | -3.49% | 19,694 | - |
| 470 | CUE | Cue Biopharma, Inc. | 25.98M | -2.86% | 454,927 | 7.10M |
| 471 | BOLD | Boundless Bio, Inc. | 25.97M | -1.69% | 46,626 | - |
| 472 | BRNS | Barinthus Biotherapeutics plc | 25.52M | 7.76% | 6,434 | 14.97M |
| 473 | SKYE | Skye Bioscience, Inc. | 25.05M | 0.17% | 206,703 | - |
| 474 | IGC | IGC Pharma, Inc. | 24.93M | -0.04% | 162,789 | 1.11M |
| 475 | IOBT | IO Biotech, Inc. | 24.46M | -5.69% | 534,762 | - |
| 476 | MRKR | Marker Therapeutics, Inc. | 24.18M | -3.33% | 183,075 | 4.69M |
| 477 | DARE | Daré Bioscience, Inc. | 23.58M | -1.20% | 31,658 | -57.13K |
| 478 | NEUP | Neuphoria Therapeutics Inc. | 23.45M | 1.87% | 46,132 | 14.99M |
| 479 | GNTA | Genenta Science S.p.A. | 23.42M | 9.03% | 109,651 | - |
| 480 | XCUR | Exicure, Inc. | 22.82M | 0.28% | 16,926 | 500.00K |
| 481 | SNTI | Senti Biosciences, Inc. | 22.61M | -3.37% | 230,233 | - |
| 482 | VTGN | Vistagen Therapeutics, Inc. | 22.15M | -5.61% | 577,271 | 789.00K |
| 483 | NNVC | NanoViricides, Inc. | 22.03M | 0.99% | 269,627 | - |
| 484 | PLRZ | Polyrizon Ltd. | 20.75M | -4.62% | 27,898 | - |
| 485 | VYNE | VYNE Therapeutics Inc. | 19.80M | -0.83% | 299,028 | 524.00K |
| 486 | ANEB | Anebulo Pharmaceuticals, Inc. | 19.29M | -2.13% | 121,716 | - |
| 487 | KLTO | Klotho Neurosciences, Inc. | 18.58M | 7.17% | 1,239,331 | - |
| 488 | KTTA | Pasithea Therapeutics Corp. | 18.47M | 0.78% | 231,569 | - |
| 489 | JUNS | Jupiter Neurosciences, Inc. | 17.90M | -6.64% | 31,862 | - |
| 490 | SER | Serina Therapeutics, Inc. | 17.47M | -6.36% | 78,428 | 116.00K |
| 491 | FBLG | FibroBiologics, Inc. | 16.50M | -1.27% | 218,238 | - |
| 492 | HOTH | Hoth Therapeutics, Inc. | 16.29M | -1.87% | 487,236 | - |
| 493 | LEXX | Lexaria Bioscience Corp. | 16.21M | -1.27% | 39,328 | 522.00K |
| 494 | CVKD | Cadrenal Therapeutics, Inc. | 16.00M | 10.23% | 84,142 | - |
| 495 | CTXR | Citius Pharmaceuticals, Inc. | 15.86M | 2.60% | 244,877 | 3.94M |
| 496 | CASI | CASI Pharmaceuticals, Inc. | 15.72M | -4.36% | 17,311 | 26.85M |
| 497 | CRIS | Curis, Inc. | 15.20M | -1.32% | 85,633 | 11.65M |
| 498 | INAB | IN8bio, Inc. | 15.14M | -3.13% | 59,157 | - |
| 499 | INTS | Intensity Therapeutics, Inc. | 14.85M | -10.12% | 95,589 | - |
| 500 | ALLR | Allarity Therapeutics, Inc. | 14.83M | -12.19% | 256,713 | - |
| 501 | QNTM | Quantum BioPharma Ltd. | 14.67M | -0.81% | 34,687 | - |
| 502 | CLRB | Cellectar Biosciences, Inc. | 14.33M | -0.88% | 13,483 | - |
| 503 | COCP | Cocrystal Pharma, Inc. | 13.90M | 2.89% | 31,963 | - |
| 504 | LNAI | Lunai Bioworks Inc. | 13.19M | -5.51% | 125,264 | - |
| 505 | TRAW | Traws Pharma, Inc. | 12.87M | 2.55% | 98,865 | 2.85M |
| 506 | MBRX | Moleculin Biotech, Inc. | 12.80M | -8.21% | 546,105 | - |
| 507 | BCAB | BioAtla, Inc. | 12.65M | 3.71% | 1,419,651 | 11.00M |
| 508 | BLRX | BioLineRx Ltd. | 12.56M | 2.84% | 5,592 | 12.74M |
| 509 | NCEL | NewcelX Ltd. | 12.31M | -2.17% | 15,917 | - |
| 510 | LGVN | Longeveron Inc. | 12.27M | 2.70% | 48,277 | 1.44M |
| 511 | GTBP | GT Biopharma, Inc. | 12.26M | 0.86% | 775,256 | - |
| 512 | GDTC | CytoMed Therapeutics Limited | 12.12M | 1.94% | 15,622 | 573.19K |
| 513 | BCDA | BioCardia, Inc. | 11.99M | -2.59% | 48,170 | 3.00K |
| 514 | MLEC | Moolec Science SA | 11.92M | -3.98% | 739,806 | 7.83M |
| 515 | KAPA | Kairos Pharma, Ltd. | 11.56M | -0.86% | 22,051 | - |
| 516 | ITRM | Iterum Therapeutics plc | 11.20M | -4.07% | 595,633 | 390.00K |
| 517 | SNGX | Soligenix, Inc. | 11.09M | -0.90% | 63,302 | 2.34K |
| 518 | PHIO | Phio Pharmaceuticals Corp. | 11.09M | -9.65% | 1,030,619 | - |
| 519 | IMNN | Imunon, Inc. | 10.95M | -1.23% | 13,395 | - |
| 520 | KALA | KALA BIO, Inc. | 10.73M | -5.99% | 336,498 | - |
| 521 | AKTX | Akari Therapeutics, Plc | 10.71M | 0.25% | 215,507 | - |
| 522 | OSRH | OSR Holdings, Inc. | 10.65M | -3.94% | 263,511 | -90.52K |
| 523 | PULM | Pulmatrix, Inc. | 10.39M | -1.46% | 4,485 | 3.00K |
| 524 | BOLT | Bolt Biotherapeutics, Inc. | 9.69M | -1.56% | 12,699 | 5.20M |
| 525 | CMMB | Chemomab Therapeutics Ltd. | 9.66M | -4.27% | 41,589 | - |
| 526 | BIVI | BioVie Inc. | 9.50M | -2.33% | 98,185 | - |
| 527 | RNAZ | TransCode Therapeutics, Inc. | 8.89M | -6.65% | 5,305 | - |
| 528 | CLGN | CollPlant Biotechnologies Ltd. | 8.87M | -0.68% | 95,918 | 2.48M |
| 529 | ICU | SeaStar Medical Holding Corporation | 8.80M | 1.24% | 28,395 | 881.00K |
| 530 | NCNA | NuCana plc | 8.74M | -2.10% | 18,932 | - |
| 531 | GRDX | GridAI Technologies Corp. | 8.67M | -5.15% | 83,133 | - |
| 532 | QNCX | Quince Therapeutics, Inc. | 8.36M | -7.46% | 22,390,207 | - |
| 533 | ERNA | Ernexa Therapeutics Inc. | 8.26M | -17.25% | 1,231,940 | 1,000.00 |
| 534 | XTLB | XTL Biopharmaceuticals Ltd. | 8.19M | -1.43% | 28,862 | 968.00K |
| 535 | PHGE | BiomX Inc. | 8.14M | -2.29% | 17,261 | - |
| 536 | LIMN | Liminatus Pharma, Inc. | 8.09M | -3.90% | 6,960,020 | - |
| 537 | CALC | CalciMedica, Inc. | 7.80M | 3.80% | 500,675 | - |
| 538 | EVGN | Evogene Ltd. | 7.67M | -7.54% | 120,176 | 8.02M |
| 539 | ALZN | Alzamend Neuro, Inc. | 7.49M | -2.48% | 47,017 | - |
| 540 | MBIO | Mustang Bio, Inc. | 7.30M | 9.02% | 53,961 | - |
| 541 | KPRX | Kiora Pharmaceuticals, Inc. | 7.26M | -3.88% | 48,494 | 20.00K |
| 542 | QNRX | Quoin Pharmaceuticals, Ltd. | 7.22M | -8.21% | 10,519 | - |
| 543 | ADXN | Addex Therapeutics Ltd | 7.22M | -2.70% | 1,134 | 198.82K |
| 544 | ASBP | Aspire Biopharma Holdings, Inc. | 7.18M | -2.72% | 211,062 | 1.94K |
| 545 | PMCB | PharmaCyte Biotech, Inc. | 7.12M | -2.57% | 99,123 | - |
| 546 | JAGX | Jaguar Health, Inc. | 6.83M | -4.17% | 120,444 | 11.79M |
| 547 | REVB | Revelation Biosciences, Inc. | 6.74M | 1.43% | 129,037 | - |
| 548 | EDSA | Edesa Biotech, Inc. | 6.68M | -11.40% | 5,020,833 | - |
| 549 | IMRN | Immuron Limited | 6.67M | -0.06% | 7,106 | 4.78M |
| 550 | APVO | Aptevo Therapeutics Inc. | 6.65M | -4.58% | 14,014 | - |
| 551 | CELZ | Creative Medical Technology Holdings, Inc. | 6.64M | -2.31% | 15,176 | 6.00K |
| 552 | APM | Aptorum Group Limited | 6.44M | -1.29% | 21,692 | - |
| 553 | TOVX | Theriva Biologics, Inc. | 6.43M | -8.39% | 17,109,331 | - |
| 554 | TCRT | Alaunos Therapeutics, Inc. | 6.07M | 4.70% | 6,748 | 6.00K |
| 555 | PPBT | Purple Biotech Ltd | 5.96M | -10.31% | 267,292 | - |
| 556 | CLDI | Calidi Biotherapeutics, Inc. | 5.78M | 7.97% | 102,991 | - |
| 557 | CANF | Can-Fite BioPharma Ltd. | 5.72M | 4.73% | 31,264 | 560.00K |
| 558 | APRE | Aprea Therapeutics, Inc. | 5.30M | -7.35% | 255,793 | 488.24K |
| 559 | VIVS | VivoSim Labs, Inc. | 5.27M | 1.51% | 92,205 | 142.00K |
| 560 | CDIO | Cardio Diagnostics Holdings, Inc. | 5.26M | 28.57% | 76,561,042 | 15.78K |
| 561 | XBIO | Xenetic Biosciences, Inc. | 5.15M | -1.32% | 3,061 | 2.86M |
| 562 | CYCN | Cyclerion Therapeutics, Inc. | 5.10M | -1.47% | 8,354 | 2.86M |
| 563 | BGMS | Bio Green Med Solution, Inc. | 5.10M | - | 36,214 | 81.00K |
| 564 | MTVA | MetaVia Inc. | 4.97M | -0.64% | 109,900 | - |
| 565 | SLXN | Silexion Therapeutics Corp | 4.88M | -1.27% | 22,295 | - |
| 566 | PCSA | Processa Pharmaceuticals, Inc. | 4.76M | -7.89% | 36,323 | - |
| 567 | DCOY | Decoy Therapeutics Inc. | 4.74M | -7.04% | 95,174 | - |
| 568 | BRTX | BioRestorative Therapies, Inc. | 4.68M | -18.47% | 7,166,680 | 383.40K |
| 569 | INDP | Indaptus Therapeutics, Inc. | 4.53M | 9.78% | 33,795 | - |
| 570 | ACXP | Acurx Pharmaceuticals, Inc. | 4.23M | -10.27% | 63,960 | - |
| 571 | ELAB | PMGC Holdings Inc. | 4.19M | -11.03% | 434,656 | 285.95K |
| 572 | GNPX | Genprex, Inc. | 4.13M | -4.30% | 223,618 | - |
| 573 | GOVX | GeoVax Labs, Inc. | 4.02M | -1.92% | 80,631 | 3.35M |
| 574 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 3.94M | -5.56% | 18,144 | 1.36M |
| 575 | MTNB | Matinas BioPharma Holdings, Inc. | 3.91M | -4.36% | 14,137 | - |
| 576 | SILO | Silo Pharma, Inc. | 3.81M | -2.88% | 108,416 | 72.10K |
| 577 | GRI | GRI Bio, Inc. | 3.60M | -2.35% | 59,031 | - |
| 578 | GLMD | Galmed Pharmaceuticals Ltd. | 3.56M | -5.25% | 130,526 | - |
| 579 | HCWB | HCW Biologics Inc. | 3.33M | -3.98% | 170,947 | 422.03K |
| 580 | DRMA | Dermata Therapeutics, Inc. | 3.22M | -30.05% | 2,066,289 | - |
| 581 | ENVB | Enveric Biosciences, Inc. | 3.09M | -8.26% | 629,815 | - |
| 582 | PPCB | Propanc Biopharma, Inc. | 3.04M | -5.48% | 861,118 | - |
| 583 | OGEN | Oragenics, Inc. | 2.94M | -0.14% | 19,716 | - |
| 584 | PBM | Psyence Biomedical Ltd. | 2.87M | -4.43% | 1,139,239 | - |
| 585 | ADIL | Adial Pharmaceuticals, Inc. | 2.72M | -4.30% | 40,368 | - |
| 586 | ARTL | Artelo Biosciences, Inc. | 2.66M | -6.38% | 70,869 | - |
| 587 | SPRC | SciSparc Ltd. | 2.66M | -7.25% | 93,094 | 1.31M |
| 588 | XRTX | XORTX Therapeutics Inc. | 2.59M | - | 71,089 | - |
| 589 | LYRA | Lyra Therapeutics, Inc. | 2.57M | -2.68% | 12,565 | 600.00K |
| 590 | SCNI | Scinai Immunotherapeutics Ltd. | 2.50M | -5.26% | 24,169 | 1.15M |
| 591 | BBLG | Bone Biologics Corporation | 2.15M | - | 16,462 | - |
| 592 | CMND | Clearmind Medicine Inc. | 2.10M | -5.65% | 16,583 | - |
| 593 | CNSP | CNS Pharmaceuticals, Inc. | 1.99M | 0.63% | 13,281 | - |
| 594 | AZTR | Azitra, Inc. | 1.80M | -5.84% | 987,481 | 7.50K |
| 595 | CDT | CDT Equity Inc. | 1.73M | -19.29% | 11,863,893 | - |
| 596 | VRAX | Virax Biolabs Group Limited | 1.58M | -5.33% | 96,232 | 2.99K |
| 597 | ENSC | Ensysce Biosciences, Inc. | 1.44M | -0.75% | 3,718,775 | 4.49M |
| 598 | ABP | Abpro Holdings, Inc. | 1.42M | -34.76% | 3,258,991 | 183.00K |
| 599 | ONCO | Onconetix, Inc. | 1.18M | 5.28% | 116,399 | 1.22M |
| 600 | BDRX | Biodexa Pharmaceuticals Plc | 972.99K | -10.08% | 212,528 | 104.90K |
| 601 | ADTX | Aditxt, Inc. | 900.62K | -9.24% | 179,152 | 5.95K |